{"id":"molar-sodium-lactate","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypernatremia"},{"rate":null,"effect":"Fluid overload"},{"rate":null,"effect":"Hyperkalemia (if co-administered with potassium-sparing agents)"},{"rate":null,"effect":"Phlebitis at infusion site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sodium lactate acts as an alkalinizing agent by increasing serum bicarbonate and pH, while simultaneously providing lactate that can be metabolized by the liver and muscles for energy. It is used to correct metabolic acidosis by shifting the acid-base balance toward alkalinity and supplying an alternative fuel source that reduces reliance on anaerobic metabolism.","oneSentence":"Molar Sodium Lactate is a buffering agent that increases blood pH and provides lactate as a metabolic substrate to counteract acidosis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:22:01.136Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metabolic acidosis correction in critical care settings"},{"name":"Lactic acidosis management"}]},"trialDetails":[{"nctId":"NCT07107399","phase":"PHASE2, PHASE3","title":"Therapeutic Effect of Microfragmented Adipose Tissue (Lipogems) Injection on Maximum Interincisal Opening Versus Injectable Platelet-rich Plasma (PRP) for the Treatment of Anterior Disc Displacement With Reduction : A Randomized Clinical Trial","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-08-05","conditions":"TMJ Disc Disorder","enrollment":16},{"nctId":"NCT04141371","phase":"PHASE3","title":"Molar Sodium Lactate Filling in Severe Meningeal Hemorrhage","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2022-02-14","conditions":"Subarachnoid Hemorrhage, Aneurysmal","enrollment":3},{"nctId":"NCT05004610","phase":"PHASE2","title":"Hypertonic Lactate After Cardiac Arrest","status":"RECRUITING","sponsor":"Erasme University Hospital","startDate":"2025-02-19","conditions":"Cardiac Arrest, Ischemia Reperfusion Injury, Anoxic Brain Injury","enrollment":125},{"nctId":"NCT04488874","phase":"PHASE3","title":"Sodium Lactate and Brain Relaxation (LSD)","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2020-09-29","conditions":"Sodium Lactate, Intracranial Hypertension, Brain Relaxation","enrollment":50},{"nctId":"NCT02034682","phase":"NA","title":"The Effect of Hydroxyethylstarch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte®) Compared to Gelatine (Geloplasma®) on Microvascular Reactivity and Tissue Oxygen Saturation During Haemodilution Measured With Near-infrared Spectroscopy","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2014-01","conditions":"Microvascular Reactivity, Tissue Oxygen Saturation","enrollment":40},{"nctId":"NCT01981655","phase":"PHASE2","title":"0.5M Na Lactate Solution in Acute Heart Failure (AHF)","status":"COMPLETED","sponsor":"Nepean Blue Mountains Local Health District","startDate":"2009-12","conditions":"Acute Heart Failure","enrollment":41},{"nctId":"NCT00995683","phase":"PHASE2, PHASE3","title":"Preventive Sodium Lactate and Traumatic Brain Injury","status":"COMPLETED","sponsor":"Institut d'Anesthesiologie des Alpes Maritimes","startDate":"2009-06","conditions":"Head Trauma","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":44,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Molar Sodium Lactate","genericName":"Molar Sodium Lactate","companyName":"Centre Hospitalier Universitaire de Nice","companyId":"centre-hospitalier-universitaire-de-nice","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Molar Sodium Lactate is a buffering agent that increases blood pH and provides lactate as a metabolic substrate to counteract acidosis. Used for Metabolic acidosis correction in critical care settings, Lactic acidosis management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}